Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Catton

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 19, 2017
External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancerDavid Tiberi, George Rodrigues, Tom Pickles, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
Urology Practice|April 27, 2023
Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal TherapyDiana E Magee, Douglas C Cheung, Amanda E Hird, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Lancet (London, England)|July 10, 2002
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trialBrian O'Sullivan, Aileen M Davis, Robert Turcotte, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 15, 2022
Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-LinacJennifer Dang, Vickie Kong, Winnie Li, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 7, 2022
Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapyVickie C Kong, Jennifer Dang, Winnie Li, et al.
Sarcoma|December 23, 2011
Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution ExperienceKurt R Weiss, David J Biau, Rej Bhumbra, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 19, 2017
External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancerDavid Tiberi, George Rodrigues, Tom Pickles, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
Urology Practice|April 27, 2023
Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal TherapyDiana E Magee, Douglas C Cheung, Amanda E Hird, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Lancet (London, England)|July 10, 2002
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trialBrian O'Sullivan, Aileen M Davis, Robert Turcotte, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 15, 2022
Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-LinacJennifer Dang, Vickie Kong, Winnie Li, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 7, 2022
Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapyVickie C Kong, Jennifer Dang, Winnie Li, et al.
Sarcoma|December 23, 2011
Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution ExperienceKurt R Weiss, David J Biau, Rej Bhumbra, et al.
Pageof 14